Physician profile
John T Deel
NPI 1013116946
$2,538.65
in general payments reported to CMS, 2019-2025
22 companies · $375 in 2025
The $375 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,344 · 2020: $213 · 2021: $108 · 2022: $65.25 · 2023: $182 · 2024: $252 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.63 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,281.82 | 2019-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic Vascular, INC. | $185.17 | 2019-2020 | |
| Kls-Martin L.P. | $147.78 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $141.58 | 2023-2025 | Lifevest |
| Edwards Lifesciences Corporation | $127.78 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biom'Up France Sas | $121.50 | 2020 | |
| Stryker Corporation | $72.86 | 2019 | |
| Baxter Healthcare | $64.38 | 2023-2025 | Perclot, Preveleak |
| Cardiva Medical, INC. | $59.96 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Smith+Nephew, INC. | $58.33 | 2019-2025 | Pico 7 |
| Abbott Laboratories | $42.60 | 2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $38.38 | 2024 | Impella |
| Csl Behring | $31.84 | 2019-2024 | Kcentra |
| Ethicon US, LLC | $27.17 | 2021 | |
| Medtronic, INC. | $24.26 | 2023 | Penditure |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $19.75 | 2024 | |
| Daiichi Sankyo INC. | $18.97 | 2024 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.12 | 2025 | Jardiance |
| United Therapeutics Corporation | $16.06 | 2025 | Tyvaso |
| Boston Scientific Corporation | $15.54 | 2025 | Watchman Flx |
| Bolton Medical INC | $13.82 | 2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Biotronik INC. | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Deel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.